Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Aimovig
Dosage Form : Injectable Solution
Dosage Strength : 70mg/ml
Packaging :
Approval Date : 13/07/2018
Application Number : 66748
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Aimovig
Dosage Form : Solution For Injection
Dosage Strength : 140mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Aimovig
Dosage Form : Solution For Injection
Dosage Strength : 70mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Aimovig
Dosage Form : Solution For Injection
Dosage Strength : 70mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Prescription
Registration Country : Estonia
Brand Name : Aimovig
Dosage Form : Solution For Injection
Dosage Strength : 140mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia
Regulatory Info : Prescription
Registration Country : Estonia
Brand Name : Aimovig
Dosage Form : Solution For Injection
Dosage Strength : 70mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Aimovig
Dosage Form : Solution For Injection
Dosage Strength : 140mg
Packaging :
Approval Date : 26-04-2019
Application Number : 28106151018
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Aimovig
Dosage Form : Solution For Injection
Dosage Strength : 140mg
Packaging :
Approval Date : 26-04-2019
Application Number : 28106151118
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Aimovig
Dosage Form : Solution For Injection
Dosage Strength : 70mg
Packaging :
Approval Date : 26-07-2018
Application Number : 28105962017
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Aimovig
Dosage Form : Solution For Injection
Dosage Strength : 70mg
Packaging :
Approval Date : 26-07-2018
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Annual Reports
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 378
2019 Revenue in Millions : 306
Growth (%) : 24
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 164
2019 Revenue in Millions : 103
Growth (%) : 59
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 317
2020 Revenue in Millions : 378
Growth (%) : -16
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 215
2020 Revenue in Millions : 164
Growth (%) : 31
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 218
2021 Revenue in Millions : 215
Growth (%) : 1
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 414
2021 Revenue in Millions : 317
Growth (%) : 31
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 266
2022 Revenue in Millions : 218
Growth (%) : 22
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 312
2023 Revenue in Millions : 266
Growth (%) : 17
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 119
2017 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 306
2018 Revenue in Millions : 119
Growth (%) : 157
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Patents & EXCLUSIVITIES
ABOUT THIS PAGE
